Related Experiment Videos
Human type-1 angiotensin II (AT1) receptor gene structure and function
1Institut National de la Santé et de la Recherche Médicale U36, Chaire de Médecine Expérimentale, Collège de France, Paris, France.
Clinical and Experimental Pharmacology & Physiology. Supplement
|January 1, 1996
Summary
Understanding angiotensin II receptor (AT1) gene expression is crucial for hypertension and cardiac failure treatments. Alternative splicing of AT1 mRNA, particularly involving exon 2 and exon 3, significantly impacts receptor protein production and function.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Pharmacology
Background:
- The type-1 angiotensin II (AngII) receptor (AT1) is a key drug target for hypertension and cardiac failure.
- Understanding the regulation of AT1 receptor expression is vital for therapeutic development.
Framework:
- A single human AT1 gene encodes a pre-mRNA with five exons.
- Alternative splicing of AT1 pre-mRNA generates mature mRNAs with varying translation efficiencies.
- Two functional AT1 receptor isoforms are produced through alternative splicing.
Implementation:
- Exon 2 inclusion in AT1 mRNA significantly inhibits downstream open reading frame (ORF) translation.
- Transcripts with exon 3 spliced to exon 5 encode a functional AT1 receptor isoform with an amino-terminal extension.
- Exon 4 is rarely incorporated into mature AT1 mRNA.
Implications:
- AT1 receptor expression is regulated by complex alternative splicing patterns, not just promoter activity or RNA stability.
- Analysis of AT1 gene splicing is essential for a comprehensive understanding of receptor expression regulation.
- These findings have implications for developing targeted therapies for cardiovascular diseases.